Topics

Beam Therapeutics goes public via $192.5M IPO

14:40 EST 13 Feb 2020 | Elsevier Business Intelligence

Beam Therapeutics Inc. (precision genetic medicines based on a proprietary base editing technology) netted $192.5M through it...

Original Article: Beam Therapeutics goes public via $192.5M IPO

NEXT ARTICLE

More From BioPortfolio on "Beam Therapeutics goes public via $192.5M IPO"

Quick Search